Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 18.14 USD -0.77%
Market Cap: 198.5m USD
Have any thoughts about
Medifast Inc?
Write Note

Intrinsic Value

The intrinsic value of one MED stock under the Base Case scenario is 20.53 USD. Compared to the current market price of 18.14 USD, Medifast Inc is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MED Intrinsic Value
20.53 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medifast Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MED?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Consumer products Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Medifast Inc

Provide an overview of the primary business activities
of Medifast Inc.

What unique competitive advantages
does Medifast Inc hold over its rivals?

What risks and challenges
does Medifast Inc face in the near future?

Has there been any significant insider trading activity
in Medifast Inc recently?

Summarize the latest earnings call
of Medifast Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medifast Inc.

Provide P/S
for Medifast Inc.

Provide P/E
for Medifast Inc.

Provide P/OCF
for Medifast Inc.

Provide P/FCFE
for Medifast Inc.

Provide P/B
for Medifast Inc.

Provide EV/S
for Medifast Inc.

Provide EV/GP
for Medifast Inc.

Provide EV/EBITDA
for Medifast Inc.

Provide EV/EBIT
for Medifast Inc.

Provide EV/OCF
for Medifast Inc.

Provide EV/FCFF
for Medifast Inc.

Provide EV/IC
for Medifast Inc.

Show me price targets
for Medifast Inc made by professional analysts.

What are the Revenue projections
for Medifast Inc?

How accurate were the past Revenue estimates
for Medifast Inc?

What are the Net Income projections
for Medifast Inc?

How accurate were the past Net Income estimates
for Medifast Inc?

What are the EPS projections
for Medifast Inc?

How accurate were the past EPS estimates
for Medifast Inc?

What are the EBIT projections
for Medifast Inc?

How accurate were the past EBIT estimates
for Medifast Inc?

Compare the revenue forecasts
for Medifast Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medifast Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medifast Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medifast Inc compared to its peers.

Compare the P/E ratios
of Medifast Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Medifast Inc with its peers.

Analyze the financial leverage
of Medifast Inc compared to its main competitors.

Show all profitability ratios
for Medifast Inc.

Provide ROE
for Medifast Inc.

Provide ROA
for Medifast Inc.

Provide ROIC
for Medifast Inc.

Provide ROCE
for Medifast Inc.

Provide Gross Margin
for Medifast Inc.

Provide Operating Margin
for Medifast Inc.

Provide Net Margin
for Medifast Inc.

Provide FCF Margin
for Medifast Inc.

Show all solvency ratios
for Medifast Inc.

Provide D/E Ratio
for Medifast Inc.

Provide D/A Ratio
for Medifast Inc.

Provide Interest Coverage Ratio
for Medifast Inc.

Provide Altman Z-Score Ratio
for Medifast Inc.

Provide Quick Ratio
for Medifast Inc.

Provide Current Ratio
for Medifast Inc.

Provide Cash Ratio
for Medifast Inc.

What is the historical Revenue growth
over the last 5 years for Medifast Inc?

What is the historical Net Income growth
over the last 5 years for Medifast Inc?

What is the current Free Cash Flow
of Medifast Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medifast Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medifast Inc

Current Assets 225m
Cash & Short-Term Investments 170m
Receivables 8.2m
Other Current Assets 46.8m
Non-Current Assets 66.3m
PP&E 51.3m
Other Non-Current Assets 15m
Current Liabilities 72.4m
Accounts Payable 66.3m
Accrued Liabilities 6.1m
Non-Current Liabilities 11.5m
Other Non-Current Liabilities 11.5m
Efficiency

Earnings Waterfall
Medifast Inc

Revenue
674.5m USD
Cost of Revenue
-176.7m USD
Gross Profit
497.8m USD
Operating Expenses
-486.9m USD
Operating Income
10.8m USD
Other Expenses
-3.5m USD
Net Income
7.3m USD

Free Cash Flow Analysis
Medifast Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MED Profitability Score
Profitability Due Diligence

Medifast Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
56/100
Profitability
Score

Medifast Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

MED Solvency Score
Solvency Due Diligence

Medifast Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
76/100
Solvency
Score

Medifast Inc's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MED Price Targets Summary
Medifast Inc

Wall Street analysts forecast MED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MED is 17.6 USD with a low forecast of 16.67 USD and a high forecast of 18.9 USD.

Lowest
Price Target
16.67 USD
8% Downside
Average
Price Target
17.6 USD
3% Downside
Highest
Price Target
18.9 USD
4% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MED?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MED News

Other Videos

Profile

Medifast Inc Logo
Medifast Inc

Country

United States of America

Industry

Consumer products

Market Cap

198.4m USD

Dividend Yield

36.33%

Description

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

Contact

MARYLAND
Owings Mills
11445 Cronhill Dr
+17327640619.0
www.medifast1.com

IPO

1993-12-30

Employees

984

Officers

Executive Chairman & CEO
Mr. Daniel R. Chard
Chief Financial Officer
Mr. James P. Maloney CPA
Chief Business Operations Officer
Mr. Anthony E. Tyree
Executive VP, General Counsel & Corporate Secretary
Mr. Jason L. Groves Esq.
Chief Field Operations Officer
Mr. Nicholas M. Johnson
VP of Finance & Chief Accounting Officer
Mr. Jonathan Barrett MacKenzie
Show More
Vice President of Investor Relations
Mr. Steven Zenker
Chief Human Resources Officer
Ms. Claudia C. Greninger
Show Less

See Also

Discover More
What is the Intrinsic Value of one MED stock?

The intrinsic value of one MED stock under the Base Case scenario is 20.53 USD.

Is MED stock undervalued or overvalued?

Compared to the current market price of 18.14 USD, Medifast Inc is Undervalued by 12%.

Back to Top